Srinivas Rao - 21 Mar 2025 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Reporting relationship: Co-Founder and Chief Executive Officer
Issuer ticker: ATAI
Reported as of: 21 Mar 2025
Net transaction value: -$101,814
SEC form: 4
Accepted by SEC: 24 Mar 2025, 21:00:08 UTC
Prior SEC filing: 19 Mar 2025
Next SEC filing: 15 Aug 2025
Source filing: View source filing
Reporting owner signature: /s/ Ryan Barrett, Attorney-in-fact

Key filing fact

Srinivas Rao filed Form 4 for ATAI Life Sciences N.V. (ATAI) on 24 Mar 2025.

Key facts

This page summarizes Srinivas Rao's Form 4 filing for ATAI Life Sciences N.V. (ATAI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 24 Mar 2025, 21:00.

Change

Previous filing in this sequence was filed on 19 Mar 2025.
Current net transaction value: -$101,814.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATAI transaction

Common Shares

Sale

Transaction value: $101,814
Shares: -75,418
Change %: -26%
Price: $1.35
Shares after: 212,942
Date: 21 Mar 2025
Ownership: Direct
Footnotes: F1

ATAI holding

Common Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 3,500
Date: 21 Mar 2025
Ownership: By Spouse

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares sold to satisfy the Reporting Person's tax liability on vesting of restricted stock units.

SEC remarks

Co-Founder and Chief Executive Officer

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .